Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion
Recruiting · Not applicable · NCT06348394
Conditions: Left Atrial Appendage Closure
At a glance
- Research payments reported, 2025
- $68,000
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 444
About the trial
- Sponsor
- Baylor Research Institute
- Tested
- Intracardiac Echocardiography (device), Traditional transesophageal echocardiography (device)
- Dates
- Started 2025-02-25; completion 2030-12-30
- Results posted
- Not yet
This single-center, prospective, randomized study will evaluate the safety and feasibility of Intracardiac echocardiography (ICE)-guided Left atrial appendage closure (LAAC) when compared to the traditional Transesophageal echocardiography (TEE) approach.
From ClinicalTrials.gov, last updated 2026-09-03. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $68,000 in research payments for this study in 2025 (2 payments).
Products named: Ice 3d
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Baylor Scott & White the Heart Hospital, Plano $68,000
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.